Ā | Use of GCs (n= 57) | No use of GCs (n= 90) |
---|---|---|
Age at delivery in years, mean (SD) | 33.15 (3.80) | 31.93 (3.67) |
Disease duration in years, median (range) | 6.07 (0.22-28.57) | 5.18 (0.14-28.54) |
Gestational age at delivery in weeks, mean (SD) | 38.44 (2.30) | 39.85 (1.27)f |
Anti-CCP positive, n (%) | 39 (68.4) | 51 (56.7) |
Rheumatoid factor (IgM) positive, n (%) | 47 (82.5) | 63 (70.0) |
Presence of erosions, n (%) | 49 (86) | 56 (62.2)f |
Dosage of prednisone (mg/day), median (range) | 7.5 (2.5-20) | - |
Number of DMARDs before conception, median (range) | 2 (0-5) | 1 (0-4)f |
Breastfeeding (6 weeks postpartum), n (%) | 13 (22.8) | 47 (52.2)f |
DAS28 ā„3.2 in first trimester, n (%)a | 33 (70.2) | 38 (55.9) |
Moderate/good response during pregnancy, n (%)b | 15 (45.5) | 17 (43.6) |
Very early flare, n (%)c | 9 (17.3) | 18 (21.7) |
Early flare, n (%)d | 9 (18.0) | 20 (24.4) |
Late flare, n (%)e | 10 (21.3) | 27 (35.5) |